REV 5901A (REV 5901 HCl) is an orally active leukotriene receptor antagonist and 5-lipoxygenase inhibitor with antimicrobial activity that attenuates colon cancer growth in mice.REV 5901A has been used in studies of asthma and myocardial infarction. REV 5901A is used to study asthma and myocardial infarction.
Molekulargewicht:
371.9
Reinheit:
99.74%
CAS Nummer:
[92532-23-5]
Formel:
C22H26ClNO2
Target-Kategorie:
Lipoxygenase|||Leukotriene Receptor|||Antibiotic
T21821L
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten